Mangoceuticals, Inc.
MGRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $59 | $739 | $683 | $23 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $19 | $0 | $0 |
| Other Curr. Assets | $17 | $61 | $12 | $0 |
| Total Curr. Assets | $76 | $818 | $695 | $23 |
| Property Plant & Equip (Net) | $62 | $215 | $292 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $15,233 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $17 | $17 | $0 |
| Total NC Assets | $15,295 | $232 | $309 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $15,371 | $1,051 | $1,003 | $23 |
| Liabilities | – | – | – | – |
| Payables | $838 | $141 | $34 | $0 |
| Short-Term Debt | $215 | $64 | $224 | $39 |
| Tax Payable | $0 | $7 | $3 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $373 | $0 | $0 | $0 |
| Total Curr. Liab. | $1,425 | $211 | $261 | $39 |
| LT Debt | $0 | $65 | $129 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $65 | $129 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $65 | $129 | $185 | $0 |
| Total Liabilities | $1,425 | $276 | $389 | $39 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $2 | $1 | $1 |
| Retained Earnings | -$20,807 | -$11,228 | -$2,016 | -$18 |
| AOCI | -$10 | $0 | $0 | $0 |
| Other Equity | $34,762 | $12,001 | $2,628 | $0 |
| Total Equity | $13,946 | $775 | $614 | -$17 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$1 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $15,371 | $1,051 | $1,003 | $23 |
| Net Debt | $156 | -$610 | -$330 | $17 |